NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £592,363,416 (£710,836,100 inc. VAT) |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | South East, South West, London, East Midlands, West Midlands, North East, North West, East of England |
| Deadline | 26 Mar 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-051a9d |
Awards (58)
This procurement was awarded to 29 suppliers. Values shown are per-award; the notice total is £592,363,416.
| Supplier | Value | Date | Status |
|---|---|---|---|
| ABBVIE LTD shared | £813,863,584 | 31 May 2026 | pending |
| ABBVIE LTD shared | · | · | active |
| ACCORD-UK LTD shared | £813,863,584 | 31 May 2026 | pending |
| ACCORD-UK LTD shared | · | · | active |
| Alfasigma UK Limited shared | £813,863,584 | 31 May 2026 | pending |
| ALFASIGMA UK LIMITED shared | · | · | active |
| AMGEN LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| AMGEN LIMITED shared | £18,903,212 | 31 May 2026 | pending |
| AMGEN LIMITED shared | · | · | active |
| AVENTIS PHARMA LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| AVENTIS PHARMA LIMITED t-a Sanofi shared | · | · | active |
| BIOGEN IDEC LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| BIOGEN IDEC LIMITED shared | £18,903,212 | 31 May 2026 | pending |
| BIOGEN IDEC LIMITED shared | · | · | active |
| Biosimilar Collaborations Ireland Limited shared | £813,863,584 | 31 May 2026 | pending |
| BIOSIMILAR COLLABORATIONS IRELAND LIMITED shared | · | · | active |
| CELLTRION HEALTHCARE UK LIMITED shared | · | · | active |
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED shared | £18,903,212 | 31 May 2026 | pending |
| DR REDDY'S LABORATORIES (UK) LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| DR REDDY'S LABORATORIES (UK) LIMITED shared | · | · | active |
| FRESENIUS KABI LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| FRESENIUS KABI LIMITED shared | £18,903,212 | 31 May 2026 | pending |
| FRESENIUS KABI LIMITED shared | · | · | active |
| GEDEON RICHTER (UK) LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| GEDEON RICHTER (UK) LIMITED shared | £18,903,212 | 31 May 2026 | pending |
| GEDEON RICHTER (UK) LIMITED shared | · | · | active |
| GLAXOSMITHKLINE UK LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| GLAXOSMITHKLINE UK LIMITED shared | · | · | active |
| JANSSEN-CILAG LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| JANSSEN-CILAG LIMITED shared | £18,903,212 | 31 May 2026 | pending |
| JANSSEN-CILAG LIMITED shared | · | · | active |
| MILPHARM LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| MILPHARM LIMITED shared | · | · | active |
| ORGANON PHARMA (UK) LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| ORGANON PHARMA (UK) LIMITED shared | · | · | active |
| ORIFARM UK LTD shared | £813,863,584 | 31 May 2026 | pending |
| ORIFARM UK LTD shared | · | · | active |
| PFIZER LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| PFIZER LIMITED shared | · | · | active |
| ROCHE PRODUCTS LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| ROCHE PRODUCTS LIMITED shared | · | · | active |
| SAMSUNG BIOEPIS UK LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| SAMSUNG BIOEPIS UK LIMITED shared | · | · | active |
| SANDOZ LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| SANDOZ LIMITED shared | £18,903,212 | 31 May 2026 | pending |
| SANDOZ LIMITED shared | · | · | active |
| SWEDISH ORPHAN BIOVITRUM LTD shared | £813,863,584 | 31 May 2026 | pending |
| SWEDISH ORPHAN BIOVITRUM LTD shared | · | · | active |
| TEVA UK LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| TEVA UK LIMITED shared | · | · | active |
| THORNTON & ROSS LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| THORNTON & ROSS LIMITED shared | £18,903,212 | 31 May 2026 | pending |
| THORNTON & ROSS LIMITED shared | · | · | active |
| UCB PHARMA LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| UCB PHARMA LIMITED shared | · | · | active |
| ZENTIVA PHARMA UK LIMITED shared | £813,863,584 | 31 May 2026 | pending |
| ZENTIVA PHARMA UK LIMITED shared | · | · | active |
description
NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731
Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
documents
- https://www.find-tender.service.gov.uk/Notice/016135-2026 , tenderNotice
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12389 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12390 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12391 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12392 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12393 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12394 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12395 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12396 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12397 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12398 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12399 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12400 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12401 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12402 , biddingDocuments
- https://www.find-tender.service.gov.uk/Notice/Attachment/A-12403 , biddingDocuments
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
7 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 May 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 023859-2025 |
| 3 Jun 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 029487-2025 |
| 14 Jan 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 002947-2026 |
| 18 Feb 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 014706-2026 |
| 23 Feb 2026 | Tender notice (UK4) | Procurement Act 2023 | 016135-2026 |
| 9 Jun 2026 | Contract award (UK6) | Procurement Act 2023 | 054102-2026 |
| 10 Jul 2026 | Contract details (UK7) | Procurement Act 2023 | 065041-2026 |
more from NHS England
- Coaching services for trainee doctors, dentists and pharmacists · £36,000 · 30 Jul 2026
- Exam Support Packages for EoE GP Registrars · £72,673 · 24 Jul 2026
- Refer a Patient - Adult ECMO 2026/27 · £99,362 · 23 Jul 2026
- Higher Specialist Scientist Training Programme (HSST) · £42,186,231 · 23 Jul 2026
- Imaging National Lecture Series · £400,000 · 22 Jul 2026
- NHS National Framework for Lenvatinib · £35,833,000 · 22 Jul 2026
- The Practice Education Facilitator role in Return to Practice · £20,000 · 22 Jul 2026
- Pharmacy Technician Clinical Skills Development · £300,000 · 22 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
- LW158 IMP Support (FAME) · Liverpool School of Tropical Medicine · £0
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.